Off-label, But Lucrative

Big pharma profits when doctors prescribe a drug for a disorder other than the one that earned FDA approval. The practice ranges from evidence-based to highly egregious.  One in five prescriptions written in the United States is for a drug that hasn’t been approved for what’s ailing the patient. That factoid from the Agency for … Continued